HPV vaccination is given to protect against?

NORCET 2 - 2021 (shift-1)

Obstetrics & Gynaecology

Easy

Appeared in: NORCET 2 - 2021 (shift-1)

Explanation

The primary and most well-established purpose of HPV vaccination is the prevention of cervical cancer.
Human Papillomavirus (HPV) infection, particularly with high-risk serotypes 16 and 18, is the causative agent in over 70-80% of all cervical cancer cases.
The vaccine stimulates the production of antibodies against the L1 capsid protein of the HPV types included in the vaccine, preventing the virus from causing persistent infection which can lead to cancerous changes.
As seen in the image, Gardasil 9 protects against nine HPV types, including the seven high-risk types (16, 18, 31, 33, 45, 52, 58) that cause the majority of cervical and other anogenital cancers.

Option B: This option is too general. While the most common type of cervical cancer is squamous cell carcinoma (SCC), the vaccine's indication is for the prevention of cancer in a specific organ (the cervix), not for all SCCs, which can occur elsewhere in the body due to other causes (e.g., sun exposure on the skin).
Option C: Breast cancer is not associated with the Human Papillomavirus. Its risk factors are primarily related to genetics (e.g., BRCA1/2 mutations), hormonal influences, and lifestyle factors.
Option D: Lung cancer is not caused by HPV. The primary cause of lung cancer is tobacco smoking, with other risk factors including exposure to radon, asbestos, and air pollution.

Visual 1: Infographic - A chart comparing the different HPV vaccines (Gardasil 9, Gardasil, Cervarix), the specific HPV types they cover, and the diseases they prevent. This helps clarify the scope of protection for each vaccine.
Visual 2: Diagram - A flowchart illustrating the progression from HPV infection to persistent infection, development of cervical intraepithelial neoplasia (CIN), and finally to invasive cervical cancer. This visually explains the disease process that the vaccine interrupts.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Indication for Human Papillomavirus (HPV) Vaccination as background academic context rather than a clinical decision trigger.
A key nursing role is patient education. Nurses must strongly advocate for HPV vaccination in the target age group (routinely 11-12 years, as early as 9) to ensure maximum effectiveness, as the vaccine is most beneficial before the onset of sexual activity.
Nurses must counsel patients and parents that even after vaccination, routine cervical cancer screening (e.g., Pap tests) must continue as per guidelines, because the vaccine does not protect against all cancer-causing HPV types.
Patient safety is paramount. After administering the vaccine, the nurse should have the adolescent sit or lie down for 15 minutes to monitor for and prevent injury from a potential syncopal (fainting) episode, which can occur with any injection in this age group.

How to Approach the Question

First, identify the core of the question, which is asking for the primary disease prevented by HPV vaccination.
Recall the link between specific viruses and cancers. HPV is strongly and most famously linked to cervical cancer.
Analyze the options. 'Cervical cancer' is a specific disease.
'Squamous cell carcinoma' is a histological type of cancer, which is less specific than an organ-based cancer. While related, it's not the primary public health target.
'Breast cancer' and 'Lung cancer' are common cancers, but their primary causes are not viral, eliminating them as correct choices.
Conclude that 'Cervical cancer' is the most accurate and direct answer for the primary purpose of the HPV vaccine.

Concept Tested & Keywords

Concept Tested: Indication for Human Papillomavirus (HPV) Vaccination
Stem keywords: HPV vaccination, protect against
Lead-in keywords: BEST, MOST RELEVANT CLUE
Clinical cues: The image shows Gardasil 9, a specific brand of the HPV vaccine, confirming the question's context.

Q2V3uomNqdnnDwQ-u3mwcB